ArticleNature chemical biology2022

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.

Payton A-B Weidenbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.